Study suggests gastric bypass can reduce cardiovascular disease risk, irrespective of weight loss

Last month, the Eu­ro­pean Med­i­cines Agency be­gan look­ing in­to re­ports of sui­ci­dal ideation and thoughts of self-harm by users of GLP-1 med­i­cines such as No­vo

The FDA is strength­en­ing its fo­cus on us­ing math­e­mat­i­cal sim­u­la­tion and mod­el­ing to guide drug de­vel­op­ment with a new cen­ter of ex­cel­lence housed in the